Medications for Chronic Rhinosinusitis With Multiple Nasal Polyps

4 results

  • dupixent - dupilumab injection, solution

    (Dupilumab)
    Sanofi-Aventis U.S. Llc
    DUPIXENT treats moderate-to-severe atopic dermatitis (6 months+), asthma (6 years+), chronic rhinosinusitis with nasal polyps (12 years+), eosinophilic esophagitis (1 year+), prurigo nodularis, COPD, chronic spontaneous urticaria (12 years+), bullous pemphigoid, and allergic fungal rhinosinusitis in eligible adult and pediatric patients.
    Medication Details
    Drug Interactions

  • nucala - mepolizumab injection, powder, for solution

    (Mepolizumab)
    Glaxosmithkline Llc
    Nucala treats severe eosinophilic asthma (age 6+), chronic rhinosinusitis with nasal polyps (adults), eosinophilic COPD (adults), eosinophilic granulomatosis with polyangiitis (EGPA), and hypereosinophilic syndrome (age 12+). Not for acute bronchospasm.
    Medication Details
    Drug Interactions

  • tezspire - tezepelumab - ekko injection, solution

    (Tezepelumab-Ekko)
    Amgen Inc
    Tezspire is indicated as add-on maintenance treatment for adults and patients aged 12 and older with severe asthma, and for inadequately controlled chronic rhinosinusitis with nasal polyps (CRSwNP). Not for relief of acute bronchospasm or status asthmaticus.
    Medication Details
    Drug Interactions

  • xolair - omalizumab injection, solution

    (Omalizumab)
    Genentech, Inc.
    Xolair treats moderate-to-severe persistent asthma (ages 6+) with perennial allergen sensitivity, chronic rhinosinusitis with nasal polyps (adults 18+), IgE-mediated food allergy (ages 1+) to reduce accidental exposure reactions, and chronic spontaneous urticaria (ages 12+) uncontrolled by antihistamines.
    Medication Details
    Drug Interactions